164 related articles for article (PubMed ID: 37026525)
1. NCoA3 upregulation in breast cancer‑associated adipocytes elicits an inflammatory profile.
Lira MC; Rosa FD; Aiello I; Machado MS; Palma AG; Paz L; Güemes MCS; Burlando S; Azurmendi PJ; Paladino N; Costas MA; Rubio MF
Oncol Rep; 2023 May; 49(5):. PubMed ID: 37026525
[TBL] [Abstract][Full Text] [Related]
2. Decreased expression of microRNA-17 and microRNA-20b promotes breast cancer resistance to taxol therapy by upregulation of NCOA3.
Ao X; Nie P; Wu B; Xu W; Zhang T; Wang S; Chang H; Zou Z
Cell Death Dis; 2016 Nov; 7(11):e2463. PubMed ID: 27831559
[TBL] [Abstract][Full Text] [Related]
3. NCOA3 coactivator is a transcriptional target of XBP1 and regulates PERK-eIF2α-ATF4 signalling in breast cancer.
Gupta A; Hossain MM; Miller N; Kerin M; Callagy G; Gupta S
Oncogene; 2016 Nov; 35(45):5860-5871. PubMed ID: 27109102
[TBL] [Abstract][Full Text] [Related]
4. NCOA3 is a selective co-activator of estrogen receptor α-mediated transactivation of PLAC1 in MCF-7 breast cancer cells.
Wagner M; Koslowski M; Paret C; Schmidt M; Türeci O; Sahin U
BMC Cancer; 2013 Dec; 13():570. PubMed ID: 24304549
[TBL] [Abstract][Full Text] [Related]
5. Nuclear receptor coactivator 3 transactivates proinflammatory cytokines in collagen-induced arthritis.
Sun X; Chen J; Chen X; Ma J; Xiao L; Yao S; Dang X
Cytokine; 2023 Jan; 161():156074. PubMed ID: 36323191
[TBL] [Abstract][Full Text] [Related]
6. miR-17-5p Regulates Differential Expression of NCOA3 in Pig Intramuscular and Subcutaneous Adipose Tissue.
Han H; Gu S; Chu W; Sun W; Wei W; Dang X; Tian Y; Liu K; Chen J
Lipids; 2017 Nov; 52(11):939-949. PubMed ID: 28921416
[TBL] [Abstract][Full Text] [Related]
7. NR5A2 synergizes with NCOA3 to induce breast cancer resistance to BET inhibitor by upregulating NRF2 to attenuate ferroptosis.
Qiao J; Chen Y; Mi Y; Jin H; Huang T; Liu L; Gong L; Wang L; Wang Q; Zou Z
Biochem Biophys Res Commun; 2020 Sep; 530(2):402-409. PubMed ID: 32536370
[TBL] [Abstract][Full Text] [Related]
8. Circ_0001667 knockdown blocks cancer progression and attenuates adriamycin resistance by depleting NCOA3 via releasing miR-4458 in breast cancer.
Cui Y; Fan J; Shi W; Zhou Z
Drug Dev Res; 2022 Feb; 83(1):75-87. PubMed ID: 34227151
[TBL] [Abstract][Full Text] [Related]
9. α-Naphthoflavone modulates inflammatory response in adipocytes-macrophages interaction through NFκB signaling.
Sun Y; Xie M; Huang T; Zhang X; Lei S; Shi Q; Wang S; Fan C; Zhang J
Int J Clin Exp Pathol; 2014; 7(11):7768-74. PubMed ID: 25550814
[TBL] [Abstract][Full Text] [Related]
10. Nuclear Receptor Coactivator NCOA3 Regulates UV Radiation-Induced DNA Damage and Melanoma Susceptibility.
de Semir D; Bezrookove V; Nosrati M; Dar AA; Miller JR; Leong SP; Kim KB; Liao W; Soroceanu L; McAllister S; Debs RJ; Schadendorf D; Leachman SA; Cleaver JE; Kashani-Sabet M
Cancer Res; 2021 Jun; 81(11):2956-2969. PubMed ID: 33766890
[TBL] [Abstract][Full Text] [Related]
11. NCOA3 Loss Disrupts Molecular Signature of Chondrocytes and Promotes Posttraumatic Osteoarthritis Progression.
Zhang B; Li Z; Wang W; Guo J; Kang S; Liu S; Li H; Wang D; Qi X
Cell Physiol Biochem; 2018; 49(6):2396-2413. PubMed ID: 30261507
[TBL] [Abstract][Full Text] [Related]
12. NCOA3-mediated upregulation of mucin expression via transcriptional and post-translational changes during the development of pancreatic cancer.
Kumar S; Das S; Rachagani S; Kaur S; Joshi S; Johansson SL; Ponnusamy MP; Jain M; Batra SK
Oncogene; 2015 Sep; 34(37):4879-89. PubMed ID: 25531332
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor alpha and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma: mechanism of desmoplastic reaction.
Meng L; Zhou J; Sasano H; Suzuki T; Zeitoun KM; Bulun SE
Cancer Res; 2001 Mar; 61(5):2250-5. PubMed ID: 11280794
[TBL] [Abstract][Full Text] [Related]
14. MAD2L2 inhibits colorectal cancer growth by promoting NCOA3 ubiquitination and degradation.
Li Y; Li L; Chen M; Yu X; Gu Z; Qiu H; Qin G; Long Q; Fu X; Liu T; Li W; Huang W; Shi D; Kang T; Luo M; Wu X; Deng W
Mol Oncol; 2018 Mar; 12(3):391-405. PubMed ID: 29360267
[TBL] [Abstract][Full Text] [Related]
15. Association of NCOA3 polymorphisms with breast cancer risk.
Burwinkel B; Wirtenberger M; Klaes R; Schmutzler RK; Grzybowska E; Försti A; Frank B; Bermejo JL; Bugert P; Wappenschmidt B; Butkiewicz D; Pamula J; Pekala W; Zientek H; Mielzynska D; Siwinska E; Bartram CR; Hemminki K
Clin Cancer Res; 2005 Mar; 11(6):2169-74. PubMed ID: 15788663
[TBL] [Abstract][Full Text] [Related]
16. The cooperative function of nuclear receptor coactivator 1 (NCOA1) and NCOA3 in placental development and embryo survival.
Chen X; Liu Z; Xu J
Mol Endocrinol; 2010 Oct; 24(10):1917-34. PubMed ID: 20685850
[TBL] [Abstract][Full Text] [Related]
17. Adipocyte-derived IL-6 and leptin promote breast Cancer metastasis via upregulation of Lysyl Hydroxylase-2 expression.
He JY; Wei XH; Li SJ; Liu Y; Hu HL; Li ZZ; Kuang XH; Wang L; Shi X; Yuan ST; Sun L
Cell Commun Signal; 2018 Dec; 16(1):100. PubMed ID: 30563531
[TBL] [Abstract][Full Text] [Related]
18. NCOA3 is a critical oncogene in thyroid cancer via the modulation of major signaling pathways.
Li Y; Liang J; Dang H; Zhang R; Chen P; Shao Y
Endocrine; 2022 Jan; 75(1):149-158. PubMed ID: 34251576
[TBL] [Abstract][Full Text] [Related]
19. Vaspin suppresses cytokine-induced inflammation in 3T3-L1 adipocytes via inhibition of NFκB pathway.
Zieger K; Weiner J; Krause K; Schwarz M; Kohn M; Stumvoll M; Blüher M; Heiker JT
Mol Cell Endocrinol; 2018 Jan; 460():181-188. PubMed ID: 28756250
[TBL] [Abstract][Full Text] [Related]
20. Interaction with adipocyte stromal cells induces breast cancer malignancy via S100A7 upregulation in breast cancer microenvironment.
Sakurai M; Miki Y; Takagi K; Suzuki T; Ishida T; Ohuchi N; Sasano H
Breast Cancer Res; 2017 Jun; 19(1):70. PubMed ID: 28629450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
